Conditional myeloid-specific deletion of Ube2n hinders YUMM1.7 melanoma growth

Kelsie Schiavone, Adam Pecoraro, Afsa Khawar, Kathleen Zhang, Vaibhav Jain, Simon Gregory, Daniel T. Starczynowski, Jennifer Y. Zhang · 2026

Read Conditional myeloid-specific deletion of Ube2n hinders YUMM1.7 melanoma growth by Kelsie Schiavone, Adam Pecoraro, Afsa Khawar, Kathleen Zhang, Vaibhav Jain, Simon Gregory, Daniel T. Starczynowski, Jennifer Y. Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13645565.txt.

Description

Kelsie Schiavone and seven colleagues report a mouse study on a protein called UBE2N and its role in helping melanoma tumors grow. The team used mice whose immune cells of the myeloid type could have the Ube2n gene switched off at a chosen time. They then tracked a melanoma line called YUMM1.7. The question was whether removing this protein from those immune cells would slow the tumor.

Switching the gene off did slow tumor growth, and tumors held fewer myeloid cells afterward. Levels of several immune signals in the tumor setting also shifted. In lab-grown immune cells, blocking the protein lowered a signal called SPP1, and fluid from those cells left T cells with fewer exhaustion markers. The results point to myeloid UBE2N as a possible target for future melanoma treatments.

Catalog record

CREATORKelsie Schiavone, Adam Pecoraro, Afsa Khawar, Kathleen Zhang, Vaibhav Jain, Simon Gregory, Daniel T. Starczynowski, Jennifer Y. Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13645565

Browse the full library · About the Tower of Babel